Skip to content

Analysis of Red Blood Cell Integrity and Efficiency of Recovery Using a Novel Surgical Sponge-Blood Recovery Device (ProCell): Delayed Impact

Analysis of Red Blood Cell Integrity and Efficiency of Recovery Using a Novel Surgical Sponge-Blood Recovery Device (ProCell): Delayed Impact

Status
Withdrawn
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05545956
Enrollment
0
Registered
2022-09-19
Start date
2023-05-09
Completion date
2025-01-01
Last updated
2024-12-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Blood Recovery

Keywords

Open Heart Surgery, Heart Transplant, Lung Transplant, ProCell

Brief summary

The purpose of this research study is to compare two methods of recovering blood from surgical sponges used during heart and lung surgeries. The two methods are: 1) manually wringing sponges by hand, and 2) automated wringing sponges by an FDA approved suction device. Both methods are already in use in heart and lung surgeries at University Hospitals at the discretion of the surgeon.

Interventions

PROCEDUREHand Wrung

Hand wrung refers to manually wringing surgical sponges by hand.

ProCell wrung refers to automated wringing surgical sponges by an FDA approved suction device (ProCell).

Sponsors

ProCell Surgical Inc.
CollaboratorUNKNOWN
University Hospitals Cleveland Medical Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Subject)

Masking description

Subjects will be blinded to the intervention.

Eligibility

Sex/Gender
ALL
Age
18 Years to 89 Years
Healthy volunteers
No

Inclusion criteria

* Undergoing heart or lung transplant, redo sternotomy, aortic surgery, and/or multi-valve repairs/replacements; and * At University Hospitals Cleveland Medical Center.

Exclusion criteria

* Patients with known bleeding disorders, including disseminated intravascular coagulation (DIC), prothrombin deficiency, factor V deficiency, factor VII deficiency, factor X deficiency, factor XI deficiency (hemophilia C), Glanzmann disease, hemophilia A, hemophilia B, idiopathic thrombocytopenic purpura (ITP), and Von Willebrand disease (types I, II, and III); * Patients undergoing emergent or emergent salvage surgery; and * Patients actively participating in another clinical trial which could affect outcomes.

Design outcomes

Primary

MeasureTime frameDescription
Units of Packed Red Blood Cells TransfusedUp to 72 Hours Post-OperativeUnits of packed red blood cells transfused will be measured.
Change in Level of HematocritBaseline, Post-Operative Hours 0, 6, 12, 18, 24, 48, and 72Level of hematocrit will be measured at baseline and post-operative.
Change in Level of Plasma Free HemoglobinBaseline, Post-Operative Hours 0, 6, 12, 18, 24, 48, and 72Level of plasma free hemoglobin will be measured at baseline and post-operative.
Change in Volume of BloodBaseline, Post-Processing (Up to 120 Minutes)Volume of blood will be measured at baseline and post-processing.

Secondary

MeasureTime frameDescription
Change in Weight of Surgical SpongeBaseline, Post-Procedure (Up to 5 Minutes)Weight of surgical sponges will be measured at baseline and post-procedure.
Change in Number of Fragmented Red Blood CellsBaseline, Post-Operative Hours 0, 6, 12, 18, 24, 48, and 72Number of fragmented red blood cells will be measured at baseline and post-operative.
Time to Wring SpongesUp to 120 MinutesTime in seconds to wring sponges will be measured.
Change in Level of Lactate DehydrogenaseBaseline, Post-Operative Hours 0, 6, 12, 18, 24, 48, and 72Level of lactate dehydrogenase will be measured at baseline and post-operative.
Change in Level of HaptoglobinBaseline, Post-Operative Hours 0, 6, 12, 18, 24, 48, and 72Level of haptoglobin will be measured at baseline and post-operative.
Change in Level of BilirubinBaseline, Post-Operative Hours 0, 6, 12, 18, 24, 48, and 72Level of bilirubin will be measured at baseline and post-operative.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026